GALMED PHARMACEUTICALS LTD. (GLMD)
Clinical trial NCT06502561 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2025-11-17 3. enrollment type: ESTIMATED → ACTUAL 4. allocation: NON_RANDOMIZED → RANDOMIZED
Clinical trial NCT06502561 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2025-11-17 3. enrollment type: ESTIMATED → ACTUAL 4. allocation: NON_RANDOMIZED → RANDOMIZED
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical